ArXiv TLDR

Joint Treatment Effect Estimation from Incomplete Healthcare Data: Temporal Causal Normalizing Flows with LLM-driven Evolutionary MNAR Imputation

🐦 Tweet
2605.05125

Olivia Jullian Parra, Sara Zoccheddu, David Catalan Cerezo, Tom Forzy, Franziska Ulrich + 5 more

cs.LGcs.AI

TLDR

This paper introduces a two-stage pipeline for robust treatment effect estimation from incomplete EHRs using a causal normalizing flow and an LLM-driven imputer.

Key contributions

  • Proposes a two-stage pipeline for robust treatment effect estimation from incomplete longitudinal EHRs.
  • Introduces CausalFlow-T, a DAG-constrained normalizing flow for exact counterfactual inference.
  • Develops an LLM-driven evolutionary imputer for MNAR data, outperforming statistical baselines.
  • Validated on real-world EHRs, yielding treatment effect estimates consistent with RCTs.

Why it matters

Existing methods struggle with high missingness and temporal confounding in EHRs, limiting robust treatment effect estimation. This paper offers an integrated solution for causal inference from real-world healthcare data. This enables more reliable insights from observational studies, crucial for medical research and decision-making.

Original Abstract

Target trial emulation (TTE) enables causal questions to be studied with observational data when randomized controlled trials (RCTs) are infeasible. Yet treatment-effect methods often address causal estimation, missingness, and temporal structure separately, limiting their robustness in electronic health records (EHRs), where time-varying confounding and missing-not-at-random (MNAR) biomarkers can reach 50%--80%. We propose a two-stage pipeline for treatment effect estimation from incomplete longitudinal EHRs. First, CausalFlow-T, a directed acyclic graph (DAG)-constrained normalizing flow with long short-term memory (LSTM)-encoded patient history, performs exact invertible counterfactual inference, avoiding approximation errors from variational inference and separating confounding through explicit causal structure. Ablations on four synthetic and one semi-synthetic benchmark with known counterfactuals show that DAG constraints and exact inference address distinct failure modes: neither compensates for the other. Second, because CausalFlow-T requires completed inputs, we introduce an LLM-driven evolutionary imputer that proposes executable imputation operators rather than individual entries, and evaluate it with three large language model (LLM) backends, including two open-source models. Across 30%--80% MNAR missingness, this imputer achieves the best pooled rank over biomarker and causal metrics, leading in point-wise accuracy and temporal extrapolation while preserving average treatment effect (ATE) recovery as statistical baselines degrade. On Swiss primary-care EHRs from adults with type 2 diabetes initiating a GLP-1 receptor agonist or SGLT-2 inhibitor, the pipeline estimates a per-protocol weight-loss difference of -0.98 kg [95% CI -1.01, -0.96] favoring GLP-1 receptor agonists, consistent with randomized evidence and obtained from realistically incomplete real-world EHRs.

📬 Weekly AI Paper Digest

Get the top 10 AI/ML arXiv papers from the week — summarized, scored, and delivered to your inbox every Monday.